Sterile Pharmaceutical Preparations
41 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a disadvantage of using PVC containers for drug storage?

  • Drugs can leach DEHP into solutions. (correct)
  • It can cause breakage during transportation.
  • They require special aeration equipment to drain.
  • It is transparent.
  • Which type of glass cannot be reused due to the removal of its internal layer through washing and autoclaving?

  • Durable glass
  • Type II glass (correct)
  • Type I glass
  • Type III glass
  • What is a key characteristic of Type I glass compared to other types?

  • It is the least expensive type of glass.
  • It is made solely of soda lime.
  • It is chemically inert and reusable. (correct)
  • It releases alkalinity with water.
  • Which of the following is true about the grades of water for injection?

    <p>WFI is free of pyrogens and of high chemical purity.</p> Signup and view all the answers

    What characteristic distinguishes semi-rigid polyethylene containers from flexible PVC containers?

    <p>Semi-rigid containers require the use of an aeration tube due to their design.</p> Signup and view all the answers

    What is the primary distinction between IV injection and IV infusion?

    <p>IV injection is for rapid drug delivery, while IV infusion is for prolonged administration.</p> Signup and view all the answers

    Which of the following is NOT a type of sterile pharmaceutical preparation?

    <p>Topical creams</p> Signup and view all the answers

    Which statement identifies an advantage of parenteral drug administration?

    <p>It ensures administration of drugs that are ineffective via GIT.</p> Signup and view all the answers

    Which of the following best describes Large Volume Parenterals (LVP)?

    <p>They are typically administered via a catheter over a longer duration.</p> Signup and view all the answers

    Which of these scenarios would be a limitation of parenteral administration?

    <p>Patient discomfort due to the invasive nature of injections.</p> Signup and view all the answers

    What is one of the key general limitations of parenteral preparations?

    <p>Risk of contamination and difficult error correction.</p> Signup and view all the answers

    Which of the following conditions would most likely justify the use of parenteral nutrition (PN)?

    <p>Patients unable to take food orally due to medical conditions.</p> Signup and view all the answers

    Which injection method allows for the fastest systemic administration and is preferred in emergencies?

    <p>Intravenous route (IV)</p> Signup and view all the answers

    What is a significant risk associated with intravenous (IV) injections?

    <p>Introduction of pyrogens or microorganisms</p> Signup and view all the answers

    What is the maximum volume for intramuscular injections?

    <p>5 ml</p> Signup and view all the answers

    Which injection type is specifically used for allergic testing?

    <p>Intradermal injection (ID)</p> Signup and view all the answers

    What is a disadvantage of intramuscular (IM) injections compared to intravenous (IV) injections?

    <p>Slower onset of action</p> Signup and view all the answers

    Intrathecal injections are administered into which part of the body?

    <p>Spinal fluid</p> Signup and view all the answers

    Which injection method is commonly used for animal studies?

    <p>Intraperitoneal injection (IP)</p> Signup and view all the answers

    What is the primary reason IV infusions are preferred in clinical settings?

    <p>Can administer large doses of fluids, electrolytes, and drugs</p> Signup and view all the answers

    Which injection type requires more expertise due to the risk of complications like infiltration?

    <p>Intravenous (IV)</p> Signup and view all the answers

    What is the volume classification for small volume parenterals (SVP)?

    <p>&lt; 100 ml</p> Signup and view all the answers

    Which of the following forms can be included as a fluid type for small volume parenterals?

    <p>Solutions, emulsions, and suspensions</p> Signup and view all the answers

    Which method can help achieve controlled drug delivery in parenteral preparations?

    <p>Using less soluble salts</p> Signup and view all the answers

    What ratio of crystalline to amorphous insulin is found in insulin lente?

    <p>7:3</p> Signup and view all the answers

    Which of the following is NOT a specification for parenteral preparations?

    <p>Color intensity</p> Signup and view all the answers

    What is a critical concern for the presence of pathogens in parenteral preparations?

    <p>Can result in severe systemic issues, potentially fatal</p> Signup and view all the answers

    Which formulation could potentially have a longer duration of action?

    <p>Oily injections</p> Signup and view all the answers

    What is the purpose of using preservatives in parenteral preparations?

    <p>To maintain sterility and prevent microbial growth</p> Signup and view all the answers

    Which of the following additives is commonly NOT found in large volume parenterals?

    <p>Preservatives</p> Signup and view all the answers

    Which condition is critical for ensuring the safety of parenteral preparations?

    <p>Tonicity balance</p> Signup and view all the answers

    Which of the following methods can be used to calculate the amount of solute required for tonicity adjustment?

    <p>Freezing point depression method</p> Signup and view all the answers

    What is one major limitation associated with the use of vials for parenteral products?

    <p>High risk of air contamination</p> Signup and view all the answers

    What is a key advantage of using pre-filled syringes over traditional vials?

    <p>Reduced risk of particle release</p> Signup and view all the answers

    Which type of agent is noted as incompatible with certain drugs?

    <p>Hypertonic agents</p> Signup and view all the answers

    In the context of packaging materials, which material is NOT commonly used?

    <p>Aluminum</p> Signup and view all the answers

    What type of stopper is used in vials for sealing?

    <p>Natural rubber stopper</p> Signup and view all the answers

    What is a characteristic of glass ampoules used for single doses?

    <p>Self-breaking neck design</p> Signup and view all the answers

    Which of the following is NOT a common packaging option for parenteral products?

    <p>Aerosol cans</p> Signup and view all the answers

    Which of the following is true regarding the clarity of LVP solutions compared to SVP solutions?

    <p>SVP solutions typically have higher clarity than LVP solutions.</p> Signup and view all the answers

    What is a requirement for making solutions isotonic?

    <p>Use of 0.9% NaCl</p> Signup and view all the answers

    Study Notes

    Sterile Pharmaceutical Preparations

    • Sterile preparations include parenteral preparations, ophthalmic preparations, dialysis solutions, irrigation solutions, radiopharmaceuticals, and plasma expanders.

    Parenteral Preparations

    • Parenteral preparations are sterile dosage forms delivered to the patient outside the alimentary canal (bypass).
    • Definition: "Parenteral preparations are sterile preparations intended for administration by injection, infusion, or implantation into human or animal bodies."
    • This method bypasses the digestive system
    • Key advantages for administration include:
      • Treating drugs with instability in the gastrointestinal tract (GIT)
      • Addressing poor absorption in the GIT
      • Administering irritating drugs
      • Treating unconscious or uncooperative patients
      • Providing rapid correction of fluid and electrolyte imbalances
      • Addressing patients experiencing nausea and vomiting
      • Offering faster onset of action in emergencies
      • Using lower drug doses and reducing side effects
      • Targeting specific organs
    • Key disadvantages include:
      • Invasive and painful nature (lower compliance)
      • Risk of injury from insertion of needles or catheters
      • Difficulties in managing errors
      • Risk of complications from toxic doses, incorrect drugs or contaminants
    • Types of injections:
      • Intramuscular (IM): Injections made into muscles (5 ml).
      • Intravenous (IV): Direct injection into the vein.
      • Subcutaneous (SC): Injections made under the skin (1.5 ml, commonly used for insulin).
      • Intradermal (ID): Injections into the skin dermis (for allergic testing, using penicillin).
      • Intraspinal (Intrathecal): Injections through the interthecal spaces into the spinal fluid (for spinal anesthesia).
      • Intraperitoneal (IP): Injection into the peritoneal cavity (commonly for animal studies).

    IV Infusion vs IV Injection

    • IV injection delivers small-volume parenterals (SVP) directly into a vein.
    • IV infusion delivers large-volume parenterals (LVP) via a catheter directly into the vein.

    Advantages of IV Infusions

    • Parenteral nutrition (PN) and Total Parenteral Nutrition (TPN)
    • Correction of fluid or electrolyte imbalances
    • Administration of large doses of drugs (antibiotics, chemotherapy)

    General Advantages of Parenteral Preparations

    • Drugs with instability in the GIT (e.g., insulin, heparin)
    • Drugs with poor GIT absorption (e.g., streptomycin)
    • GIT irritating drugs
    • Unconscious or uncooperative patients
    • Rapid correction of fluid and electrolyte imbalance
    • Nauseated patients and those vomiting
    • Shorter onset of action (emergencies)
    • Lower doses and side effects
    • Drugs targeting specific organs

    General Limitations of Parenteral Preparations

    • Invasive and painful procedures
    • Trauma from needle/catheter insertion
    • Difficulty in addressing mistakes (toxic dose, incorrect drug, contaminants)

    Common Types of Injections – Advantages

    • Intravenous (IV) Route:
      • Fastest method for systemic administration.
      • Preferred route for emergencies.
      • Enables administration of high doses of fluids, electrolytes, nutrients, and drugs for hospitalized patients.
      • Beneficial for patients with severe GIT problems (e.g., ulcers, intoxication).

    Administration and Precautions

    • IV route risk: introduction of pyrogens, toxins, and microorganisms into the bloodstream.
    • Solutions must be free of particles and air bubbles to prevent embolism which can block blood vessels.
    • Suspension or oily injections are not suitable for IV use due to restriction.
    • IV administration cannot achieve depot effect.
    • Infiltration possible (breakdown or collapse of veins), leading to edema and tissue damage. This requires skilled administration.

    Classification of Parenterals

    • Pharmaceutical classification:
      • Solutions
      • Suspensions
      • Emulsions
      • Dry powder
    • Volume-based classification:
      • Large volume parenterals (LVP)
      • Small volume parenterals (SVP)

    How to achieve controlled drug delivery

    • Increasing particle size (suspensions) and viscosity (oil solutions and suspensions)
    • Use of implants
    • Use of less soluble salts (e.g., insulin-Zn)
    • Use of crystalline rather than amorphous form (e.g., insulin lente)

    Insulin Lente

    • Insulin zinc suspension
    • An intermediate-acting porcine or human insulin with zinc salt.

    Assignments

    • Assignment 1: Investigate different insulin formulations on the market, noting their variable durations and onsets of action.
    • Assignment 2: Collect examples of different parenteral drug products, indicating active constituents, doses, labels (excipients), and reconstitution methods.

    Specifications of Parenteral Preparations

    • Sterility, completely free from microorganisms and contaminants.
    • Clarity, absence of foreign particles (dust, glass, fiber).
    • Absence of pyrogens (fever-producing toxins).
    • Tonicity (osmotic pressure).
    • pH.

    Methods of Sterilization

    • Moist heat sterilization
    • Dry heat sterilization
    • Ionizing radiation sterilization
    • Gaseous sterilization (ethylene oxide)
    • Filtration (bacterial filters)

    Preservation

    • Addition of antimicrobial agents to multi-dose vials to protect from contamination.
    • Preservatives not often added to large-volume parenterals (LVPs) because single-dose containers are typically discarded after opening.
    • The drug itself may have antimicrobial effects (e.g., methohexital sod).

    Preservation - Ideal Preservative Characteristics

    • Effective against a wide range of bacteria
    • Nontoxic at the concentration employed
    • Stable
    • Compatible with existing injection components, no interaction detected

    Commonly Used Preservatives in Multi-Dose Injections

    • Benzyl alcohol
    • Chlorocresol
    • Cresol
    • Methyl paraben
    • Propyl paraben
    • Phenol
    • Thiomersal

    Clarity

    • Parenteral solutions must be clear, free of foreign particles
    • Foreign particles are not biodegradable.

    Absence of Pyrogens

    • Parenteral solutions must be non-pyrogenic (pyrogen-free)
    • Pyrogens are fever-producing endotoxins found in the outer membrane of Gram-negative bacteria
    • Pyrogens consist of lipopolysaccharides (Lipid A linked to a central polysaccharide core).

    Sources of Pyrogens

    • Solvents (water)
    • Equipment
    • Packaging materials
    • Raw materials used

    Biological Activity of Pyrogens

    • Injection of pyrogens produces toxic effects.
    • Contamination of large-volume parenterals (LVPs) can cause serious problems.
    • Lipid A affects the thermoregulatory center in the brain (fever).
    • High doses activate the coagulation system, leading to shock and death.

    Characteristics of Pyrogens

    • Water-soluble
    • Non-volatile
    • Pass through bacterial filters
    • Heat-stable

    Depyrogenation

    • Elimination of pyrogens from solvents, equipment, and raw materials.
    • Achieved by removal or inactivation.

    Water Depyrogenation

    • Distillation (BP) removes non-volatile pyrogens from water
    • Reverse osmosis (USP) filters the water under pressure through a semi-permeable membrane.
    • Ultrafiltration helps remove pyrogens from solutions.

    Packing Materials and Equipment

    • Removing pyrogens from surfaces with non-pyrogenic water
    • Inactivation of pyrogens by dry heat at 250°C for 30 minutes (for heat-resistant glass).

    pH

    • Ideal pH of parenteral preparations: 7.4.
    • Some drugs necessitate different pH values for stability or solubility.

    Non-Neutral SVPs (IM, SC, IV)

    • Formulated at suitable pH for stability or solubility, with a low-capacity buffer system.
    • Allow rapid neutralization by natural buffer systems.
    • Common buffers: acetate, phosphate, and citrate.

    Non-Neutral SVPs (cont.)

    • Acceptable pH range for tissues: 4-9.
    • Exceeding this range can lead to irritation/harm to tissues for injection routes other than IV.

    Non-Neutral LVPs

    • IV infusions should not include buffering systems due to large volumes needing considerable volumes of buffers and this could be harmful.
    • Neutralization of LVP solutions is difficult even with low buffer capacity.

    Non-Neutral LVPs (cont.)

    • Non-neutral IV infusions should be injected slowly with low infusion rates.

    Non-Neutral LVPs (cont.)

    • Accepted pH range for non-neutral LVPs: 3-10.5.

    Tonicity (Osmotic Pressure)

    • Semi-permeable membrane separates water from electrolyte solution causing water to pass from its compartment to the electrolyte solution compartment until equilibrium.
    • Pressure required to overcome this water pressure is osmotic pressure.

    Tonicity (cont.)

    • Parenteral preparations should be isotonic to blood plasma to prevent harmful changes.
    • Hypotonic solutions have lower osmotic pressure compared to blood plasma.
    • Hypertonic solutions have higher osmotic pressure compared to blood plasma.

    Tonicity (cont.)

    • Injection of hypertonic solutions can cause painful tissue reactions, RBC shrinkage (reversible in IV), damage to delicate nerve cells.
    • Intrathecal injections must be isotonic to prevent damage to the spinal cord and cerebrospinal fluid.
    • IV injections of hypotonic solutions can cause RBC haemolysis (irreversible and fatal).

    Hypertonic Parenteral Solutions

    • Hypertonic solutions for injection can be made isotonic by dilution.
    • IM and SC hypertonic injections might cause mild pain.
    • Hypertonic IV infusions should be administered slowly via a central catheter.

    Comment

    • In some cases, hypertonic IV infusions are deliberately administered, particularly in cases of TPN where high concentrations of nutrients (e.g., 25% dextrose) are required.

    Hypotonic Parenteral Solutions

    • Made isotonic by adding electrolytes like sodium chloride or other osmotic agents (e.g., mannitol, glucose).
    • Mannitol and glucose may be incompatible with some drugs.
    • Solutions are made isotonic with 0.9% NaCl.

    Tonicity Adjustment

    • Calculate solute amount and dilution using methods:
      • Freezing point depression method
      • Sodium chloride equivalent
      • Molar concentration
      • Serum osmolarity

    Lecture Quiz

    • Comparing SVPs and LVPs regarding sterility, clarity, pyrogen absence, buffer use, non-neutral solutions, hypotonic solutions, and hypertonic solutions.

    Components of Parenteral Products

    • Container (packaging)
    • Active constituent
    • Solvent
    • Additives

    Packaging (Containers)

    • Glass ampoules
    • Rubber-stoppered vials
    • Glass and plastic bottles
    • Glass and plastic syringes
    • Prefilled syringes

    Packing Materials

    • Glass
    • Rubber
    • Plastic

    Ampoules

    • Single-dose glass container for SVPs.
    • Glass neck should be scratched (or self-breaking).
    • May release glass particles into the solution (filled under vacuum).

    Vials

    • Multi-dose and single-dose SVPs (1-100 ml)
    • Glass bottle with a rubber cap and sealed aluminum cover coated with plastic.
    • Rubber material might be natural or synthetic (butyl rubber).

    Vial Limitations

    • Incomplete sealing in multi-dose vials.
    • Air contamination during production.
    • Release of rubber particles into the solution
    • Adsorption of injection components (preservatives).

    Pre-filled Syringes

    • Advantage: solving problems of particulate release and air contamination.
    • Limitation: Cost and specific machine requirement for manufacturing.

    Plastic Containers

    • LVP single-dose IV infusion bottles (100-1000 ml)
    • Polymers (polyethylene, polypropylene, or PVC) + additives (plasticizer, opacifier).

    Plastic Containers – Disadvantages

    • Leaching of some drugs from the plastic (fat emulsions, paclitaxel, amiodarone hydrochloride, blood).
    • Drug adsorption onto PVC (e.g., nitroglycerin).
    • Low clarity and inspection potential.

    Flexible (PVC)

    • Adsorb some drugs (nitroglycerin)
    • No need for air tubes (solutions drain by gravity).

    Semi-Rigid (PE)

    • More compatible.
    • Needs aeration for solution drainage.

    Glass Bottles

    • Advantages: transparent, chemically inert, can be used with incompatible plastic materials.
    • Disadvantages: Breakage during transport, need for aeration tube or needle due to contamination risks

    Glass Bottles (Chemical Composition)

    • Consists of silicon dioxide and other oxides.
    • Three types:
      • Type III (soda lime glass): Releases alkalinity with water.
      • Type II (sulphated glass): Treated with sulfur oxide to neutralize alkalinity.
      • Type I (borosilicate glass): Doesn't release alkalinity; multiple use, more expensive.

    Glass (cont.)

    • Type II glass cannot be reused due to removed internal layer after multiple washes and autoclaving.

    Solvents for Injection

    • Aqueous (water, co-solvents)
    • Non-aqueous (oils, oily materials).

    Grades of Water

    • Water for injection (WFI): Potable water with no organisms, particles, dissolved gases/minerals; highly purified. Commonly used as a vehicle or solvent in parenteral products.
    • WFI preparation methods include: Distillation, filtration, chemical softening, deionization, pH adjustment, and reverse osmosis.

    WFI (cont.)

    • Packed in sealed containers and sterilized by moist heat for single-dose use.
    • Used to dissolve or dilute products before administration.

    Bacteriostatic Water for Injection (SWFI)

    • WFI containing a bacteriostatic agent, used in multi-dose vials.

    Co-solvents

    • Water-miscible solvents (e.g., glycerin, ethanol, propylene glycol).
    • Increase solubility and act as stabilizers for certain drugs.

    Non-aqueous Solvents (Oils)

    • Used for drugs like digoxin (solubilization).
    • Stabilize water-hydrolysable drugs (e.g., barbiturates).
    • Provide sustained drug effects (e.g., steroids).

    Major Class of Non-Aqueous Solvents

    • Fixed vegetable oils (e.g., corn oil, cottonseed oil, peanut oil, sesame oil).
    • Must be labeled.
    • May cause sensitivity reactions.
    • Mineral, volatile, and animal oils are generally not used in injections.

    Additives

    • To provide effective, safe, and elegant preparations.
    • Antimicrobial agents
    • Buffers
    • Tonicity-adjusting agents
    • Antioxidants
    • Surfactants

    Antioxidants

    • Added for stability.
    • Oxidized preferentially during product shelf life.

    Surfactants

    • Used in parenteral suspensions (preventing crystal formation and improved syringeability).
    • Also used in parenteral emulsions with examples such as Sorbitan monooleate or polyoxyethylene sorbitan monooleate

    Production of Parenteral Solutions

    • Produced in a high-standard clean room and aseptic environment,
    • Avoiding mistakes that cause contamination (microorganisms, pyrogens, particulate matter).

    Production of Parenteral Solutions – Raw Materials

    • Special, pyrogen-free grades for injections

    Production of Parenteral Solutions – Personnel

    • High training level
    • Good hygiene practices
    • Special clothing (fiber and sterile)

    Production of Parenteral Solutions – Production Area

    • Sterile rooms fitted with laminar flow hoods and HEPA filters for air purification.
    • Removes 99.97% of particles larger than 0.3 µm along with all microbial contaminants.

    Note on Laminar Flow

    • Laminar flow isn't sterilization, it maintains a contamination-free area, crucial for IV admixtures.

    Quality Control Testing and Evaluation (BP)

    • This process involves testing for containers, the entire batch, and samples within the batch.

    Tests for the Container

    • Glass containers
    • Plastic containers
    • Rubber closures

    Glass Tests

    • Surface alkalinity
    • Total alkalinity

    Plastic Container Tests (Leaching)

    • Chemical testing (color, pH, turbidity, and UV)
    • Reducing substances testing
    • Biological testing on new plastics

    Rubber Closure Tests

    • Release testing (chemicals upon autoclaving)
    • Permeability testing (force to pierce)

    Resealing Test

    • Efficiency of vial resealing as a multi-dose container.

    Fragmentation Test

    • Measuring the amount of rubber fragments inside/inside a vial.

    Tests for the Whole Batch

    • Leaker test
    • Clarity test

    Leaker Test

    • Ensures proper sealing of ampoules.
    • Immersing ampoules in a methylene blue solution after autoclaving.
    • Reject visibly-colored ampoules.

    Clarity Test

    • Tests the presence of particles exceeding 50 µm and rejects products with visible particles.

    Tests for Samples of the Batch

    • Sterility tests (referring to microbiology)
    • Pyrogen tests (detailed steps with examples in following sections)
    • Extractable volume tests (measuring the extractable volume of a container vs. the labelled volume).
    • Clarity tests (measuring and evaluating presence of sub-visible particles)

    Pyrogen Testing (Rabbit Pyrogen Test)

    • Qualitative test to detect various pyrogens.
    • Involves injecting the solution into three rabbits and monitoring body temperature changes.
    • Pyrogens increase body temperature by 0.6°C or more in any rabbit.
    • All rabbits combined readings don't exceed 1.4°C within 3 hours.

    Pyrogen Testing (cont.) – Advantages

    • Reacts similarly to human reactions.
    • Detects all types of pyrogens

    Pyrogen Testing (cont.) – Disadvantages

    • Costly
    • Time-consuming procedure
    • Low sensitivity
    • Injection components can sometimes interfere.

    Bacterial Endotoxin test

    • LAL (Limulus Amebocyte Lysate) test: An in-vitro test on gel formation when pyrogens are added to the LAL reagent.
    • LAL agent contains clotting proteins, while pyrogens aid in the clotting process.

    LAL Test (cont.) Advantages

    • Quick and less expensive than rabbit test
    • Can quantify endotoxins

    LAL Test (cont.) Disadvantages

    • Many variables (pH, ions in solution) can affect the outcome.
    • Does not detect pyrogens from gram-positive bacteria.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Explore the essentials of sterile pharmaceutical preparations, including parenteral and ophthalmic solutions. Learn about their advantages, applications, and critical roles in patient treatment. This quiz emphasizes the importance of these preparations in various medical scenarios.

    More Like This

    Sterile Products Quiz
    3 questions
    PHAR635: USP 797 Chapter 5 Quiz
    15 questions
    Use Quizgecko on...
    Browser
    Browser